Quipt Home Medical (QIPT) director exits as shares and options cashed out at $3.65

Rhea-AI Filing Summary

Quipt Home Medical director Brian Joseph Wessel reported dispositions of his equity in connection with the company’s acquisition. On March 16, 2026, all of his 75,000 stock options with a $4.99 exercise price and 116,854 common shares held directly were disposed of to the issuer under a plan of arrangement that paid $3.65 per share in cash for each common share. An additional 98,875 common shares were disposed of from the B & E Wessel Family Trust, which holds the shares for the benefit of Brian and Eliana Wessel and their children; Mr. Wessel disclaims beneficial ownership of these trust-held securities. Footnotes state that, at the effective time of the arrangement, all issued and outstanding common shares were transferred to the purchasers for cash and all vested options were surrendered for a cash payment equal to the excess, if any, of $3.65 over the option exercise price, while options with exercise prices at or above $3.65 and 80,406 restricted share units were cancelled without consideration.

Insights

M&A and insider-transactions analyst

Form 4 shows cash-out of Quipt director’s equity in a completed acquisition.

The filing describes how Quipt Home Medical was acquired under a plan of arrangement, with all common shares transferred to purchasers at $3.65 per share. Director Brian Joseph Wessel reports dispositions reflecting this cash-out, rather than open-market trading.

One entry covers 75,000 stock options with a $4.99 exercise price, while two others cover 116,854 directly held common shares and 98,875 shares held by the B & E Wessel Family Trust. Footnotes also note forfeiture of 80,406 RSUs and cancellation of out-of-the-money options.

The transactions are coded as disposition to issuer and reduce the reported holdings to zero following closing, which is typical when a company is taken private or acquired for cash. From an investment perspective this is largely mechanical, documenting the equity clean-up associated with the completed arrangement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wessel Brian Joseph

(Last) (First) (Middle)

C/O QUIPT HOME MEDICAL CORP.

1019 TOWN DRIVE

(Street)

WILDER KY 41076

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Quipt Home Medical Corp. [ QIPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/16/2026(1)		D		116,854(2)	D	$3.65	0	D
Common Shares	03/16/2026(1)		D		98,875	D	$3.65	0	I	By Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$4.99	03/16/2026		D			75,000	(4)	(4)	Common Shares	75,000	(4)	0	D

Explanation of Responses:

1. On March 16, 2026, 1567208 B.C. LTD, a company existing under the laws of British Columbia ("B.C. Purchaser"), and REM Aggregator, LLC, a Delaware limited liability company (individually, "REM Aggregator", and collectively with B.C. Purchaser ("Purchaser" or "Purchasers") acquired all of the issued and outstanding common shares (the "Shares") of Issuer under a plan of arrangement (the "Arrangement Agreement") pursuant to the Business Corporations Act (British Columbia) (the "BCBCA"). At the Effective Time (the "Effective Time") of the Arrangement Agreement each Share, other than any Shares held by shareholders who properly exercised dissent rights under the BCBCA ("Dissenting Shareholders"), were deemed to be transferred to Purchaser in consideration for the right to receive a cash payment from the Purchaser in the amount equal to US$3.65, without interest.

2. Pursuant to a forfeiture agreement entered into by Issuer and Mr. Wessel, 80,406 restricted share unit ("RSU") were forfeited immediately prior to the Effective Time and terminated in connection with the Arrangement Agreement. Each RSU is the economic equivalent of one Share.

3. Shares are held by the B & E Wessel Family Trust for the benefit of Brian Wessel, Eliana Wessel, and their children. Mr. Wessel disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that Mr. Wessel is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

4. Pursuant to the terms of the Arrangement Agreement, immediately following the Effective Time, each option exercisable to acquire one or more Shares from the Issuer (an "Option"), outstanding immediately prior to the Effective Time (whether vested or unvested) were deemed to be unconditionally vested and exercisable and will, without any further action by or on behalf of a holder of the Option, deemed to be surrendered and transferred by such holder to the Issuer in consideration for the right to receive a cash payment from the Issuer in an amount equal to the excess, if any, of US$3.65 over the exercise price of such option, less any amounts the Issuer is required to withhold for taxes, without interest. Any option for which the exercise price is equal to or greater than US$3.65 will be cancelled for no consideration.

	/s/ Brian Joseph Wessel	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Quipt Home Medical (QIPT) director Brian Wessel report?

Brian Wessel reported dispositions of all his Quipt equity on March 16, 2026. He disposed of 75,000 stock options, 116,854 directly held common shares, and 98,875 common shares held through the B & E Wessel Family Trust in connection with a cash acquisition.

At what price were Quipt Home Medical (QIPT) shares cashed out in this transaction?

Each Quipt common share was transferred to the purchasers for a cash payment of US$3.65 per share, without interest. This consideration applied to all issued and outstanding common shares other than those held by properly dissenting shareholders under the British Columbia plan of arrangement.

How were Quipt Home Medical (QIPT) stock options treated in the arrangement?

At the effective time, each outstanding option vested and was surrendered to Quipt. Holders received cash equal to the excess of US$3.65 over the option’s exercise price, less taxes. Options with exercise prices at or above US$3.65 were cancelled without any consideration.

What happened to Quipt Home Medical (QIPT) restricted share units held by Brian Wessel?

Under a forfeiture agreement with Quipt, 80,406 restricted share units held by Brian Wessel were forfeited immediately before the effective time of the arrangement. Those RSUs, each economically equivalent to one common share, were terminated in connection with completion of the acquisition transaction.

How were Quipt Home Medical (QIPT) shares held in the B & E Wessel Family Trust reported?

The filing shows 98,875 common shares disposed from the B & E Wessel Family Trust in the transaction. A footnote explains the trust holds shares for the benefit of Brian and Eliana Wessel and their children, and that Mr. Wessel disclaims beneficial ownership of these securities.

Did Brian Wessel retain any Quipt Home Medical (QIPT) shares or options after March 16, 2026?

No. The reported transactions show total shares following each disposition as zero. All directly held common shares, trust-held shares, and the 75,000 stock options were either cashed out or cancelled as part of the arrangement, leaving no remaining Quipt equity position reported.